Background: Collagen is the major protein component of the vessels. Collagen type IV is found exclusively in the basal membrane and doesn't form individual fibers, but instead is presented as a polygonal amorphous matrix that is associated with laminin and other matrix macromolecules to form the unique matrix basal membrane. Under the influence of the risk factors characterizing the metabolic syndrome, a variety of basal memrane degrading enzymes are activated. This leads to an early changes in vascular wall and accelerates the vascular aging The early manifestation of the metabolic syndrome in younger people in the modern society, leads to earlier manifestation of the complications of early vessels aging. Loss of elasticity is a key component in the pathogenesis of cardiovascular complications.
BACKGROUND:
Collagen is the major protein component of the vessels. Collagen type IV is found exclusively in the basal membrane and doesn't form individual fibers, but instead is presented as a polygonal amorphous matrix that is associated with laminin and other matrix macromolecules to form the unique matrix basal membrane. Under the influence of the risk factors characterizing the metabolic syndrome, a variety of basal memrane degrading enzymes are activated. This leads to an early changes in vascular wall and accelerates the vascular aging The early manifestation of the metabolic syndrome in younger people in the modern society, leads to earlier manifestation of the complications of early vessels aging. Loss of elasticity is a key component in the pathogenesis of cardiovascular complications.
MATERIALS AND METHODS:
A study is conducted on 62 subjects with metabolic syndrome without vascular complications and 42 controls. The main objective of the study was to compare the imunological markers of Collagen typr IV degradation in both groups and to assess their relationship with the risk factors characterizing the metabolic syndrome.
RESULTS:
When comparing the levels of Anti Coll IV Ab IgG in the control group and subjects with metabolic syndrome (respectively 0.28 + / -0.08 and 0.40 + / -0.11) a statistically significantly higher levels of Anti Coll IV Ab IgG were determined in the group with metabolic syndrome, F = 30.299, p = 0.000, Figure 1 . 
CONCLUSION:
Collagen type IV is found mainly in the basal membrane. With the launch of endothelial dysfunction in the early stages of the atherosclerotic process, the antiinflammatory endothelial protective function is depleted, allowing more aggressive intervention of the humoral and hemostatic components of the blood, followed by damage and accelerated degeneration of the basal membrane and collagen type IV. Our results reveal statistically significant higher levels of ACollIVAb IgG in the group of subjects with metabolic syndrome compared with the control group, while a significant difference was not detected in ACollIVAb IgM in both groups. When assessing the correlation between the antibody levels and the studied risk factors (components of the metabolic syndrome) in both groups were found statistically significant linear correlations between the levels of IgG ACollIVAb with diastolic blood pressure and the serum levels of blood sugar, total cholesterol, triglycerides, LDL, HDL.
Therefore, even in the early stages of the atherosclerotic process there are changes in the metabolism of collagen type IV wich is a main components constituting the basal membranes. Anticolagen type IV antibodies of class IgG, characterising the secondary immune response are elevated in the long-term chronic inflammation characterizing the metabolic syndrome and atherosclerosis, respectively, and characterize vascular aging process, whereas antibodies of class IgM, in serum during the initial response in the early stages of vascular aging are already depleted. 
